TARSUS PHARMACEUTICALS INC Share Price Today: Live Updates & Key Insights

TARSUS PHARMACEUTICALS INC share price today is $64.51, up -3.36%. The stock opened at $66 against the previous close of $66.75, with an intraday high of $66.88 and low of $63.98.

TARSUS PHARMACEUTICALS INC Share Price Chart

TARSUS PHARMACEUTICALS INC

us-stock
To Invest in {{usstockname}}
us-stock

TARSUS PHARMACEUTICALS INC Share Price Performance

$64.51 -0.0336(-3.36%) TARS at 23 Mar 2026 03:25 PM Biotechnology
Lowest Today 63.98
Highest Today 66.88
Today’s Open 66
Prev. Close 66.75
52 Week High 85.25
52 Week Low 38.51
Day’s Range: Low 63.98 High 66.88
52-Week Range: Low 38.51 High 85.25
1 day return -
1 Week return -6.22
1 month return -7.23
3 month return -21.12
6 month return +16.12
1 year return +23.02
3 year return +434.76
5 year return +107.71
10 year return -

TARSUS PHARMACEUTICALS INC Institutional Holdings

BlackRock Inc 8.88

RTW INVESTMENTS, LLC 7.84

Deep Track Capital, LP 7.05

Paradigm Biocapital Advisors LP 6.02

TANG CAPITAL MANAGEMENT LLC 5.77

Vanguard Group Inc 5.64

Jennison Associates LLC 5.24

Morgan Stanley - Brokerage Accounts 4.49

HHG PLC 3.38

Vanguard Total Stock Mkt Idx Inv 2.98

Driehaus Capital Management LLC 2.75

Assenagon Asset Management SA 2.65

iShares Russell 2000 ETF 2.24

Geode Capital Management, LLC 2.23

Amvescap Plc. 2.20

State Street Corp 2.20

Lord, Abbett & Co LLC 2.01

Macquarie Group Ltd 1.96

Frazier Life Sciences Management, L.P. 1.71

FMR Inc 1.52

The Toronto-Dominion Bank 1.45

D. E. Shaw & Co LP 1.45

Jennison SMid Cap Core Equity 1.21

PGIM Jennison Small Company A 1.21

MEDICAL BioHealth EUR Acc 1.11

Vanguard Institutional Extnd Mkt Idx Tr 0.99

Lord Abbett Developing Growth A 0.99

Fidelity Small Cap Index 0.90

iShares Russell 2000 Growth ETF 0.77

T. Rowe Price Health Sciences 0.74

Invesco Main Street Small Cap R6 0.74

Invesco Small Cap Core 0.74

Fidelity Growth Compy Commingled Pl S 0.72

iShares Biotechnology ETF 0.69

Janus Henderson Triton D 0.67

Janus Henderson US SMID Cap Growth 0.67

Jennison Health Sciences Equity 0.67

ClearBridge Small Cap Growth 0.65

ClearBridge Small Cap Growth A 0.65

Janus Henderson Global Life Sciences D 0.65

TARSUS PHARMACEUTICALS INC Market Status

Strong Buy: 6

Buy: 1

Hold: 1

Sell: 0

Strong Sell: 0

TARSUS PHARMACEUTICALS INC Fundamentals

Market Cap 2745.38 M

PB Ratio 8.2717

PE Ratio 0.0

Enterprise Value 2495.88 M

Total Assets 562.16 M

Volume 578645

TARSUS PHARMACEUTICALS INC Company Financials

Annual Revenue FY25:451360000 451.4M, FY24:182953000 183.0M, FY23:14371000 14.4M, FY22:25816000 25.8M, FY21:57027000 57.0M

Annual Profit FY25:420676000 420.7M, FY24:170127000 170.1M, FY23:13594000 13.6M, FY22:24861000 24.9M, FY21:54952000 55.0M

Annual Net worth FY25:-66418000 -66.4M, FY24:-115554000 -115.6M, FY23:-107590000 -107.6M, FY22:-62091000 -62.1M, FY21:-13827000 -13.8M

Quarterly Revenue Q4/2025:151668000 151.7M, Q3/2025:118697000 118.7M, Q2/2025:102660000 102.7M, Q1/2025:78335000 78.3M, Q3/2024:48118000 48.1M

Quarterly Profit Q4/2025:157025000 157.0M, Q3/2025:94104000 94.1M, Q2/2025:96423000 96.4M, Q1/2025:73124000 73.1M, Q3/2024:44876000 44.9M

Quarterly Net worth Q4/2025:-8373000 -8.4M, Q3/2025:-12585000 -12.6M, Q2/2025:-20340000 -20.3M, Q1/2025:-25120000 -25.1M, Q3/2024:-23420000 -23.4M

About TARSUS PHARMACEUTICALS INC & investment objective

Company Information Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States. The company offers XDEMVY, a lotilaner ophthalmic solution for the treatment of demodex blepharitis caused by the infestation of Demodex mites. It sells its products to specialty pharmacies and distributors, as well as clinics, hospitals, pharmacies, and federal healthcare programs. The company also develops TP-04, a sterile aqueous gel formulation of lotilaner in Phase 2 trial for the treatment of ocular rosacea; and TP-05, an oral tablet formulation of lotilaner in Phase 2 trial for the prevention of Lyme disease, as well as in pre-clinical studies for community malaria reduction. In addition, it is developing the lotilaner active pharmaceutical ingredient (API) to address diseases in human medicine, including eye care and infectious disease prevention. The company has a development and license agreement with Xi An Grand Chang An Pharmaceutical Co., Ltd. for the development and commercialization of TP-03 in China for the treatment of Demodex blepharitis and meibomian gland disease. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.

Organisation Biotechnology

Employees 370

Industry Biotechnology

CEO Dr. Bobak R. Azamian M.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

TARSUS PHARMACEUTICALS INC FAQs

What is the share price of TARSUS PHARMACEUTICALS INC today?

The current share price of TARSUS PHARMACEUTICALS INC is $64.51.

Can I buy TARSUS PHARMACEUTICALS INC shares in India?

Yes, Indian investors can buy TARSUS PHARMACEUTICALS INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy TARSUS PHARMACEUTICALS INC shares in India?

You can easily invest in TARSUS PHARMACEUTICALS INC shares from India by:

Can I buy fractional shares of TARSUS PHARMACEUTICALS INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of TARSUS PHARMACEUTICALS INC?

TARSUS PHARMACEUTICALS INC has a market cap of $2745.38 M.

In which sector does TARSUS PHARMACEUTICALS INC belong?

TARSUS PHARMACEUTICALS INC operates in the Biotechnology sector.

What documents are required to invest in TARSUS PHARMACEUTICALS INC stocks?

To invest, you typically need:

What is the PE and PB ratio of TARSUS PHARMACEUTICALS INC?

The PE ratio of TARSUS PHARMACEUTICALS INC is N/A and the PB ratio is 8.27.